Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
Thank you for the thoughtful analysis, Doc. You don't sound very hopeful!
It is a surprise that, so far, to quote Bastard et al:
"Conclusion. In ICU patients, auto-Abs against type I IFNs were found in at least 10% of patients with critical COVID-19 pneumonia. They were not associated with day 28 mortality."
And this is supported by the new Shanghai study.
So, the presence of auto-Abs is only useful for detecting potentially suitable patients for the P2 clinical trials.
It seems that our chances of success rely on identifying the most suitable patients from the characteristics identified from the deep dives of the data of the previous clinical trials.
Jint
We've established that Sakura7 is a sockpuppet and who they are.
With regard to Professional, most people are not "unwary" now. Especially after he claimed to offer up to £10 million in financial assistance to TFG.
Professional is Aldridge Prior
https://viz.fandom.com/wiki/Aldridge_Prior
I won't say his writings are comedy gold instead I will say his offer of multi-million pound funding for TFG is very generous.
Prof could always phone up Reade Griffith directly with his offer.
Macosta has also boasted about using this site to manipulate the share price on the Advfn forum. Whoever is behind that account has a very thin skin and fragile ego. Hence, the need to complain and brag. Oh, and take down Doc.Dan's exposé of him XD
Jonnyboy33
They know there will be a spike on an RNS announcing the P2 trials.
They will sell on the spike before the share price declines again.
This is what they have been doing since Feb 2022.
It is what I will do as well and buy at a lower price.
Hope all is well, jonnyboy.